Bausch Health Companies BHC Tax Credit Carryforward Valuation Allowance
Tax Credit Carryforward Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's tax credit carryforward valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's tax credit carryforward valuation allowance?
- Bausch Health Companies (BHC) reported tax credit carryforward valuation allowance of $2.7B in Q1 2026.
- How has Bausch Health Companies's tax credit carryforward valuation allowance changed year-over-year?
- Bausch Health Companies's tax credit carryforward valuation allowance increased by 15.0% year-over-year, from $2.34B to $2.7B.
- What is the long-term trend for Bausch Health Companies's tax credit carryforward valuation allowance?
- Over 3 years (2022 to 2025), Bausch Health Companies's tax credit carryforward valuation allowance has grown at a 5.4% compound annual growth rate (CAGR), from $2.2B to $2.58B.
- What does tax credit carryforward valuation allowance mean?
- This is a contra-asset account that reduces the carrying value of tax credit carryforwards when it is more likely than not that some or all of the credits will not be realized. It reflects management's assessment of the company's ability to generate sufficient future taxable income. A high allowance suggests uncertainty regarding the realization of tax benefits.